Pico-Tesla Magnetic Therapies (Littleton, Colorado) did not plan on using its Magneceutical therapy system, the Resonator, on Type 2 diabetes patients, Allen Braswell, the company's president/CEO, told Medical Device Daily. In fact, the company's lead indication and current area of focus is Parkinson's disease. (Medical Device Daily) Read More
